Literature DB >> 10477610

Fc-mediated nonspecific binding between fibronectin-binding protein I of Streptococcus pyogenes and human immunoglobulins.

E Medina1, G Molinari, M Rohde, B Haase, G S Chhatwal, C A Guzmán.   

Abstract

Fibronectin-binding protein I (SfbI) from Streptococcus pyogenes plays a key role in bacterial adhesion to, and invasion of, eukaryotic cells. In addition, SfbI exhibits a considerable potential as mucosal adjuvant and can trigger polyclonal activation of B cells. Here, we report that SfbI is also capable of binding human IgG in a nonimmune fashion. SfbI was reactive with IgG1, IgG2, IgG3, and IgG4 isotypes (type IIo IgG-binding profile). The affinity constant (Kd) of the SfbI-IgG interaction was in the range of 1-2 x 10(-5) M. Further studies demonstrated that the SfbI binding was mediated by the Fc component of the IgG molecule. Experiments performed using purified recombinant proteins spanning different domains of SfbI showed that the IgG-binding activity was restricted to the fibronectin-binding domains, and in particular to the fibronectin-binding repeats. Finally, the presence of recombinant SfbI resulted in an impairment of both phagocytosis of IgG-coated RBCs and Ab-dependent cell cytotoxicity by macrophages. These results demonstrated for the first time that, in addition to its major role during the colonization process, SfbI may also favor bacterial immune evasion after the onset of the infection by interfering with host clearance mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477610

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Nonimmune interaction of the SfbI protein of Streptococcus pyogenes with the immunoglobulin G F(ab')(2) fragment.

Authors:  E Medina; K Schulze; G S Chhatwal; C A Guzmán
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

2.  Identification and characterization of a novel secreted immunoglobulin binding protein from group A streptococcus.

Authors:  P K Fagan; D Reinscheid; B Gottschalk; G S Chhatwal
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

4.  Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response.

Authors:  K Schulze; E Medina; S R Talay; R J Towers; G S Chhatwal; C A Guzmán
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Identification of Plasmodium falciparum var1CSA and var2CSA domains that bind IgM natural antibodies.

Authors:  Jean-Philippe Semblat; Ahmed Raza; Sue A Kyes; J Alexandra Rowe
Journal:  Mol Biochem Parasitol       Date:  2006-01-06       Impact factor: 1.759

6.  Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model.

Authors:  J McArthur; E Medina; A Mueller; J Chin; B J Currie; K S Sriprakash; S R Talay; G S Chhatwal; M J Walker
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

7.  Evolution of sfbI encoding streptococcal fibronectin-binding protein I: horizontal genetic transfer and gene mosaic structure.

Authors:  Rebecca J Towers; Peter K Fagan; Susanne R Talay; Bart J Currie; Kadaba S Sriprakash; Mark J Walker; Gursharan S Chhatwal
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

Authors:  Joshua M Klonoski; Heather R Hurtig; Brian A Juber; Margaret J Schuneman; Thomas E Bickett; Joshua M Svendsen; Brandon Burum; Thomas A Penfound; Grigoriy Sereda; James B Dale; Michael S Chaussee; Victor C Huber
Journal:  Vaccine       Date:  2014-07-29       Impact factor: 3.641

9.  Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection.

Authors:  Chih-Feng Kuo; Nina Tsao; I-Chen Hsieh; Yee-Shin Lin; Jiunn-Jong Wu; Yu-Ting Hung
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

Review 10.  Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems Against Group A Streptococcus.

Authors:  Armira Azuar; Wanli Jin; Saori Mukaida; Waleed M Hussein; Istvan Toth; Mariusz Skwarczynski
Journal:  Vaccines (Basel)       Date:  2019-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.